To conclude, PTEN was demonstrated to be involved in the metabolic reprogramming during the progression of HCC that PTEN depletion acted as an independent biomarker for undesirable oncologic outcomes of patients with HCC while PTEN elevation contributed to the restoration of mitochondrial dysfunction by inhibiting the activation of the PI3K/Akt pathway. This evidence concerns the gene PTEN and hepatocellular carcinoma.